Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


23.12.2018

1 Ann Surg Oncol
1 BMC Cancer
3 Br J Cancer
4 Br J Surg
1 Eur J Cancer
4 Eur J Surg Oncol
5 Gastrointest Endosc
1 Gut
2 Int J Cancer
3 Int J Colorectal Dis
1 Int J Oncol
1 Lancet
1 Oncogene
2 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. YOMODA T, Sudo T, Kawahara A, Shigaki T, et al
    The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
    Ann Surg Oncol. 2018 Dec 19. pii: 10.1245/s10434-018-07110.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. BARRESI V, Cinnirella G, Valenti G, Spampinato G, et al
    Gene expression profiles in genome instability-based classes of colorectal cancer.
    BMC Cancer. 2018;18:1265.
    PubMed     Text format     Abstract available


    Br J Cancer

  3. CROSS AJ, Wooldrage K, Robbins EC, Pack K, et al
    Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study.
    Br J Cancer. 2018 Dec 19. pii: 10.1038/s41416-018-0335.
    PubMed     Text format     Abstract available

  4. SIRNIO P, Vayrynen JP, Klintrup K, Makela J, et al
    Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.
    Br J Cancer. 2018 Dec 19. pii: 10.1038/s41416-018-0357.
    PubMed     Text format     Abstract available

  5. WANG J, Shibayama Y, Zhang A, Ohsaki H, et al
    (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
    Br J Cancer. 2018 Dec 17. pii: 10.1038/s41416-018-0350.
    PubMed     Text format     Abstract available


    Br J Surg

  6. KOYAMA FC, Lopes Ramos CM, Ledesma F, Alves VAF, et al
    Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Br J Surg. 2018;105:e192-e203.
    PubMed     Text format     Abstract available

  7. PARK J, Danielsen AK, Angenete E, Bock D, et al
    Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial).
    Br J Surg. 2018;105:244-251.
    PubMed     Text format     Abstract available

  8. GRUT H, Solberg S, Seierstad T, Revheim ME, et al
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
    Br J Surg. 2018;105:295-301.
    PubMed     Text format     Abstract available

  9. VAN ZOGGEL DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, et al
    Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
    Br J Surg. 2018;105:447-452.
    PubMed     Text format     Abstract available


    Eur J Cancer

  10. SUENAGA M, Stintzing S, Cao S, Zhang W, et al
    Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial.
    Eur J Cancer. 2018;107:100-114.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  11. WANG XJ, Chi P, Zhang YY, Lin HM, et al
    Survival outcome of adjuvant radiotherapy after local excision for T2 early rectal cancer: An analysis based on the surveillance, epidemiology, and end result registry database.
    Eur J Surg Oncol. 2018;44:1865-1872.
    PubMed     Text format     Abstract available

  12. HAMMARSTROM K, Mezheyeuski A, Korsavidou Hult N, Sjoblom T, et al
    Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers.
    Eur J Surg Oncol. 2018;44:1858-1864.
    PubMed     Text format     Abstract available

  13. EVRARD S
    Autopsy of an expert consensus: End of hyperthermic intraperitoneal chemotherapy in colorectal carcinomatosis.
    Eur J Surg Oncol. 2018;44:1845-1846.
    PubMed     Text format    

  14. BUSHATI M, Rovers KP, Sommariva A, Sugarbaker PH, et al
    The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).
    Eur J Surg Oncol. 2018;44:1942-1948.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  15. UTSUMI T, Iwatate M, Sano Y
    A vanishing superficial depressed colorectal lesion in a patient with ulcerative colitis.
    Gastrointest Endosc. 2018;88:406-407.
    PubMed     Text format    

  16. REX DK, Repici A, Gross SA, Hassan C, et al
    High-definition colonoscopy versus Endocuff versus EndoRings versus full-spectrum endoscopy for adenoma detection at colonoscopy: a multicenter randomized trial.
    Gastrointest Endosc. 2018;88:335-344.
    PubMed     Text format     Abstract available

  17. CASTANEDA D, Popov VB, Verheyen E, Wander P, et al
    New technologies improve adenoma detection rate, adenoma miss rate, and polyp detection rate: a systematic review and meta-analysis.
    Gastrointest Endosc. 2018;88:209-222.
    PubMed     Text format     Abstract available

  18. ROOS VH, Bastiaansen BAJ, Dekker E
    Gastric adenomas in familial adenomatous polyposis: you only see them when you know what to look for.
    Gastrointest Endosc. 2018;88:403-405.
    PubMed     Text format    

  19. BITAR H, Zia H, Bashir M, Parava P, et al
    Impact of fellowship training level on colonoscopy quality and efficiency metrics.
    Gastrointest Endosc. 2018;88:378-387.
    PubMed     Text format     Abstract available


    Gut

  20. STJARNGRIM J, Ekbom A, Hammar U, Hultcrantz R, et al
    Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Gut. 2018 Dec 15. pii: gutjnl-2018-316651. doi: 10.1136/gutjnl-2018-316651.
    PubMed     Text format     Abstract available


    Int J Cancer

  21. REN A, Sun S, Li S, Chen T, et al
    Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32079.
    PubMed     Text format     Abstract available

  22. ZAIMENKO I, Jaeger C, Brenner H, Chang-Claude J, et al
    Non-invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: the DACHS study.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32076.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  23. BAE SU, Yang SY, Min BS
    Totally robotic modified complete mesocolic excision and central vascular ligation for right-sided colon cancer: technical feasibility and mid-term oncologic outcomes.
    Int J Colorectal Dis. 2018 Dec 17. pii: 10.1007/s00384-018-3208.
    PubMed     Text format     Abstract available

  24. BOHLOK A, Hendlisz A, Bouazza F, Galdon MG, et al
    The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
    Int J Colorectal Dis. 2018;33:1383-1391.
    PubMed     Text format     Abstract available

  25. LOFFELD RJLF, Dekkers PEP, Liberov B
    The first results of the "bevolkingsonderzoek" in the Zaanstreek region in The Netherlands.
    Int J Colorectal Dis. 2018;33:1485.
    PubMed     Text format     Abstract available


    Int J Oncol

  26. LIAO Z, Zhang H, Fan P, Huang Q, et al
    High PLK4 expression promotes tumor progression and induces epithelialmesenchymal transition by regulating the Wnt/betacatenin signaling pathway in colorectal cancer.
    Int J Oncol. 2019;54:479-490.
    PubMed     Text format     Abstract available


    Lancet

  27. VAN DER VALK MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, et al
    Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
    Lancet. 2018;391:2537-2545.
    PubMed     Text format     Abstract available


    Oncogene

  28. WIESWEG M, Kasper S, Worm K, Herold T, et al
    Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer.
    Oncogene. 2018 Dec 19. pii: 10.1038/s41388-018-0634.
    PubMed     Text format     Abstract available


    Oncol Rep

  29. RYU TY, Kim K, Son MY, Min JK, et al
    Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6938.
    PubMed     Text format     Abstract available

  30. GUO L, Ma L, Liu C, Lei Y, et al
    ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer.
    Oncol Rep. 2018 Dec 19. doi: 10.3892/or.2018.6943.
    PubMed     Text format     Abstract available


    PLoS One

  31. AGYEMANG-YEBOAH F, Yorke J, Obirikorang C, Nsenbah Batu E, et al
    Colorectal cancer survival rates in Ghana: A retrospective hospital-based study.
    PLoS One. 2018;13:e0209307.
    PubMed     Text format     Abstract available

  32. DAMIN F, Galbiati S, Soriani N, Burgio V, et al
    Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients.
    PLoS One. 2018;13:e0207876.
    PubMed     Text format     Abstract available

  33. BAAS J, Krens L, Bohringer S, Mol L, et al
    Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab.
    PLoS One. 2018;13:e0208080.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: